Logo image of TALK

TALKSPACE INC (TALK) Stock Fundamental Analysis

NASDAQ:TALK - Nasdaq - US87427V1035 - Common Stock - Currency: USD

3.16  +0.06 (+1.94%)

After market: 3.16 0 (0%)

Fundamental Rating

5

TALK gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 109 industry peers in the Health Care Providers & Services industry. TALK has a great financial health rating, but its profitability evaluates not so good. TALK shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year TALK has reported negative net income.
In the past year TALK had a positive cash flow from operations.
TALK had negative earnings in each of the past 5 years.
In the past 5 years TALK always reported negative operating cash flow.
TALK Yearly Net Income VS EBIT VS OCF VS FCFTALK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -20M -40M -60M -80M

1.2 Ratios

TALK has a Return On Assets of -0.99%. This is comparable to the rest of the industry: TALK outperforms 50.00% of its industry peers.
TALK has a Return On Equity (-1.17%) which is in line with its industry peers.
Industry RankSector Rank
ROA -0.99%
ROE -1.17%
ROIC N/A
ROA(3y)-30.84%
ROA(5y)-46.01%
ROE(3y)-37.09%
ROE(5y)-76.75%
ROIC(3y)N/A
ROIC(5y)N/A
TALK Yearly ROA, ROE, ROICTALK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 -50 -100 -150

1.3 Margins

The Gross Margin of TALK (47.04%) is better than 75.00% of its industry peers.
TALK's Gross Margin has declined in the last couple of years.
TALK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 47.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.8%
GM growth 5YN/A
TALK Yearly Profit, Operating, Gross MarginsTALK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 50 -50

More info and screens

8

2. Health

2.1 Basic Checks

TALK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, TALK has more shares outstanding
TALK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
TALK Yearly Shares OutstandingTALK Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 50M 100M 150M
TALK Yearly Total Debt VS Total AssetsTALK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

TALK has an Altman-Z score of 14.59. This indicates that TALK is financially healthy and has little risk of bankruptcy at the moment.
TALK has a better Altman-Z score (14.59) than 96.30% of its industry peers.
TALK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 14.59
ROIC/WACCN/A
WACC9.16%
TALK Yearly LT Debt VS Equity VS FCFTALK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 6.90 indicates that TALK has no problem at all paying its short term obligations.
The Current ratio of TALK (6.90) is better than 97.22% of its industry peers.
A Quick Ratio of 6.90 indicates that TALK has no problem at all paying its short term obligations.
TALK has a Quick ratio of 6.90. This is amongst the best in the industry. TALK outperforms 97.22% of its industry peers.
Industry RankSector Rank
Current Ratio 6.9
Quick Ratio 6.9
TALK Yearly Current Assets VS Current LiabilitesTALK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 50M 100M 150M 200M

More info and screens

7

3. Growth

3.1 Past

TALK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 95.45%, which is quite impressive.
TALK shows a strong growth in Revenue. In the last year, the Revenue has grown by 31.48%.
The Revenue has been growing by 25.34% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)95.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%133.33%
Revenue 1Y (TTM)31.48%
Revenue growth 3Y25.34%
Revenue growth 5YN/A
Sales Q2Q%22.65%

3.2 Future

The Earnings Per Share is expected to grow by 24.79% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 22.60% on average over the next years. This is a very strong growth
EPS Next Y105.1%
EPS Next 2Y58.97%
EPS Next 3Y45.44%
EPS Next 5Y24.79%
Revenue Next Year28.96%
Revenue Next 2Y26.19%
Revenue Next 3Y24.79%
Revenue Next 5Y22.6%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
TALK Yearly Revenue VS EstimatesTALK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
TALK Yearly EPS VS EstimatesTALK Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -0.2 -0.4 -0.6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TALK. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 49.97, TALK can be considered very expensive at the moment.
TALK's Price/Forward Earnings ratio is in line with the industry average.
TALK is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 92.49, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 49.97
TALK Price Earnings VS Forward Price EarningsTALK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

TALK's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 251.55
EV/EBITDA N/A
TALK Per share dataTALK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

TALK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as TALK's earnings are expected to grow with 45.44% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y58.97%
EPS Next 3Y45.44%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TALK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TALKSPACE INC

NASDAQ:TALK (2/3/2025, 8:00:01 PM)

After market: 3.16 0 (0%)

3.16

+0.06 (+1.94%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-29 2024-10-29/bmo
Earnings (Next)02-25 2025-02-25/amc
Inst Owners63.08%
Inst Owner Change0.03%
Ins Owners2.96%
Ins Owner Change-1%
Market Cap533.79M
Analysts81.67
Price Target4.97 (57.28%)
Short Float %3.45%
Short Ratio3.6
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)196.08%
Min EPS beat(2)100%
Max EPS beat(2)292.16%
EPS beat(4)3
Avg EPS beat(4)103.12%
Min EPS beat(4)-46.99%
Max EPS beat(4)292.16%
EPS beat(8)7
Avg EPS beat(8)61.03%
EPS beat(12)9
Avg EPS beat(12)41.31%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.34%
Min Revenue beat(2)-2.13%
Max Revenue beat(2)-0.55%
Revenue beat(4)2
Avg Revenue beat(4)1.15%
Min Revenue beat(4)-2.13%
Max Revenue beat(4)7.21%
Revenue beat(8)6
Avg Revenue beat(8)2.69%
Revenue beat(12)7
Avg Revenue beat(12)1.08%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)39.29%
EPS NQ rev (1m)-26.83%
EPS NQ rev (3m)-25%
EPS NY rev (1m)0%
EPS NY rev (3m)220%
Revenue NQ rev (1m)0.71%
Revenue NQ rev (3m)-2%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.47%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 49.97
P/S 2.94
P/FCF 251.55
P/OCF 87.65
P/B 4.54
P/tB 4.54
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)0.06
Fwd EY2%
FCF(TTM)0.01
FCFY0.4%
OCF(TTM)0.04
OCFY1.14%
SpS1.07
BVpS0.7
TBVpS0.7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.99%
ROE -1.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 47.04%
FCFM 1.17%
ROA(3y)-30.84%
ROA(5y)-46.01%
ROE(3y)-37.09%
ROE(5y)-76.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.8%
GM growth 5YN/A
F-Score7
Asset Turnover1.31
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 423.03%
Cap/Sales 2.19%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.9
Quick Ratio 6.9
Altman-Z 14.59
F-Score7
WACC9.16%
ROIC/WACCN/A
Cap/Depr(3y)23.95%
Cap/Depr(5y)117.36%
Cap/Sales(3y)0.32%
Cap/Sales(5y)0.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)95.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%133.33%
EPS Next Y105.1%
EPS Next 2Y58.97%
EPS Next 3Y45.44%
EPS Next 5Y24.79%
Revenue 1Y (TTM)31.48%
Revenue growth 3Y25.34%
Revenue growth 5YN/A
Sales Q2Q%22.65%
Revenue Next Year28.96%
Revenue Next 2Y26.19%
Revenue Next 3Y24.79%
Revenue Next 5Y22.6%
EBIT growth 1Y78.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year127.4%
EBIT Next 3Y49.34%
EBIT Next 5Y38.36%
FCF growth 1Y102.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y108.52%
OCF growth 3YN/A
OCF growth 5YN/A